Rybakowski J, Matkowski K, Linka M, Kasprowicz-Dabrowiecka A, Kanarkowski R, Lehmann W, Krzyzanowski M
Katedry i Kliniki Psychiatrii AM, Bydgoszczy.
Psychiatr Pol. 1991 May-Aug;25(3-4):111-8.
Monitored treatment of a depressed phase of unipolar affective disorder was conducted in 11 female patients receiving imipramine and in 12 females taking amitriptyline. Patients were randomly assigned to one of the drug and in 6 patients the drugs were switched because of the lack of response to the first used compound. In the imipramine treated group a satisfactory response after 4 weeks of management (less than 6 points on Hamilton's depression scale) was observed in 6 patients and in amitriptyline treated group in 5 patients. Patients displaying a satisfactory response to amitryptyline had significantly higher--as compared to remaining patients in the group--plasma levels of the drug after two and four weeks of treatment. Such an association was not observed in patients treated wtih imipramine. Severity of depression and motor retardation before the treatment was similar both in patients with satisfactory and with poor response to imipramine as well as to amitriptyline. However the intensity of anxiety symptoms was higher in patients exhibiting poor response to treatment with amitriptyline and imipramine as well.
对11名服用丙咪嗪的女性患者和12名服用阿米替林的女性患者进行了单相情感障碍抑郁期的监测治疗。患者被随机分配到其中一种药物组,6名患者因对首次使用的化合物无反应而更换药物。在丙咪嗪治疗组中,6名患者在治疗4周后(汉密尔顿抑郁量表得分低于6分)有满意的反应,在阿米替林治疗组中有5名患者有满意反应。与该组其余患者相比,对阿米替林有满意反应的患者在治疗两周和四周后的血浆药物水平显著更高。在用丙咪嗪治疗的患者中未观察到这种关联。对丙咪嗪和阿米替林反应良好和反应不佳的患者治疗前的抑郁严重程度和运动迟缓情况相似。然而,对阿米替林和丙咪嗪治疗反应不佳的患者焦虑症状强度也更高。